With cutting-edge automation, the facility can produce mRNA material for up to 100,000 doses of a COVID-19 vaccine daily, ...
Stocktwits on MSN13h
Moderna Stock Slips On Report Of CEO Relinquishing Sales Chief Role: Retail Mood DimsShares of Moderna, Inc. ($MRNA), among the frontrunners in mRNA vaccine technology, fell on Tuesday, bucking the broader market strength. The weakness came after Bloomberg reported, citing a person ...
Zacks.com on MSN19h
Should Moderna Stock Be in Your Portfolio Pre-Q3 Earnings?Moderna MRNA is set to report third-quarter 2024 earnings on Nov. 7, before the opening bell. The Zacks Consensus Estimate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback